when will tirzepatide be approved vs. Semaglutide: What You Should Know Tirzepatide (Zepbound) for weight loss

There is currently insufficient human data to confirm safety for breastfed infants

Broad service menu

Lyophilized formulations require reconstitution with bacteriostatic water before use

For people with prediabetes or insulin resistance who do not yet meet diagnostic criteria for type 2 diabetes, tirzepatide can normalize glucose metabolism before the disease progresses

Side effects: Like semaglutide, tirzepatides most common side effects are nausea, diarrhea, vomiting, stomach pain, and indigestion

semaglutide: Key differences Tirzepatide, which is the active ingredient in the brand-name drugs Mounjaro and Zepbound, is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, also known as a GIP receptor/GLP-1 receptor agonist